| Articles Reviewed |
| 1: | David J Steger et al. DOT1L/KMT4 recruitment and H3K79 methylation are ubiquitously coupled with gene transcription in mammalian cells. 2008 |
| 2: | Mathieu Lupien et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. 2008 |
| 3: | Antonella De Luca et al. Important roles of multiple Sp1 binding sites and epigenetic modifications in the regulation of the methionine sulfoxide reductase B1 (MsrB1) promoter. 2007 |
| 4: | Sergey Denissov et al. Identification of novel functional TBP-binding sites and general factor repertoires. 2007 |
| 5: | Xiaoqin Xu et al. A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members. 2007 |
| 6: | Imke Listerman et al. Extragenic accumulation of RNA polymerase II enhances transcription by RNA polymerase III. 2007 |
| 7: | Zhiqiang Zhang et al. Transcription termination factor Pcf11 limits the processivity of Pol II on an HIV provirus to repress gene expression. 2007 |
| 8: | Lingfang Shi et al. NF90 regulates inducible IL-2 gene expression in T cells. 2007 |
| 9: | Victoria H Cowling et al. The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. 2007 |
| 10: | Nancy L Vogel et al. Spermidine/Spermine N1-Acetyltransferase 2 (SSAT2) functions as a coactivator for NF-kappaB and cooperates with CBP and P/CAF to enhance NF-kappaB-dependent transcription. 2006 |
| 11: | Pablo Huertas et al. An hpr1 point mutation that impairs transcription and mRNP biogenesis without increasing recombination. 2006 |
| 12: | Mark Bieda et al. Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. 2006 |
| 13: | Natalia Gromak et al. Pause sites promote transcriptional termination of mammalian RNA polymerase II. 2006 |
| 14: | Anna Saramäki et al. Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. 2006 |
| 15: | Ronni Nielsen et al. Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery. 2006 |
| 16: | Bastian Opitz et al. Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. 2006 |
| 17: | Zhanguo Gao et al. Coactivators and corepressors of NF-kappaB in IkappaB alpha gene promoter. 2005 |
| 18: | Jason E Fish et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. 2005 |
| 19: | Christopher C Valley et al. Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus. 2005 |
| 20: | Katri Saavalainen et al. The human hyaluronan synthase 2 gene is a primary retinoic acid and epidermal growth factor responding gene. 2005 |
| 21: | Hans F Luecke et al. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. 2005 |
| 22: | Marylynn Snyder et al. The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation. 2005 |
| 23: | Irina Lassot et al. p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain. 2005 |
| 24: | I-Ching Wang et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. 2005 |
| 25: | Mathilde Calligé et al. CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome. 2005 |
| 26: | Dominique Y Begon et al. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. 2005 |
| 27: | Jason Matthews et al. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. 2005 |
| 28: | G Brett Robb et al. Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript. 2004 |
| 29: | Sarah E Aiyar et al. Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. 2004 |
| 30: | Joe F Lau et al. Role of metazoan mediator proteins in interferon-responsive transcription. 2003 |
| 31: | Janice M LaPlante et al. Antisense-mediated loss of calcium homoeostasis endoplasmic reticulum protein (CHERP; ERPROT213-21) impairs Ca2+ mobilization, nuclear factor of activated T-cells (NFAT) activation and cell proliferation in Jurkat T-lymphocytes. 2003 |
| 32: | Ying Zhang et al. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex. 2002 |
| 33: | Janeen H Trembley et al. PITSLRE p110 protein kinases associate with transcription complexes and affect their activity. 2002 |
| 34: | Nicoletta Corbi et al. The alpha-like RNA polymerase II core subunit 3 (RPB3) is involved in tissue-specific transcription and muscle differentiation via interaction with the myogenic factor myogenin. 2002 |
| 35: | Beata Fuchsová et al. Nuclear DNA helicase II is recruited to IFN-alpha-activated transcription sites at PML nuclear bodies. 2002 |
| 36: | M Zhou et al. TFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcription. 2001 |